Clinical Trial Update: Intravitreal and Intracameral DEX in NPDR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intravitreal and intracameral dexamethasone for non-proliferative diabetic retinopathy is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 3 | Status: ENROLLING_BY_INVITATION